Form D · Pharmaceuticals
Adora Animal Health Corp
Franklin, TN · CIK 0002078308
Offering snapshot reported Jul 23, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2025 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552567
Source: Form D, filed Jul 23, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas D'ambra | Director, Executive, Promoter |
| Thomas Vaughn | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2020 Fieldstone Parkway, Suite 900 200
Franklin, TN, 37069
Phone: 615-582-1002
Franklin, TN, 37069
Phone: 615-582-1002